## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -1.5% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($75.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Hudson Bay Capital Management LP Makes New Investment in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251215T105904 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has made a new investment in Ventas, Inc. ($VTR), purchasing 278,193 shares valued at approximately $17.57 million. This investment comes as Ventas demonstrates strong financials, beating EPS estimates and showing significant revenue growth. Despite a high payout ratio for its dividend, the company maintains a "Moderate Buy" consensus analyst rating.

**2. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T170843 | Somewhat-Bullish | Relevance: 98%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, continuing its strong income story alongside impressive stock performance. The company's valuation is being assessed after its robust third quarter, with one narrative suggesting it's 8.1% undervalued compared to its fair value of $84.70, driven by active portfolio management and strategic acquisitions. However, market ratios flash a caution sign, as its price-to-sales ratio is higher than the broader North American Health Care REITs group.

**3. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T172952 | Somewhat-Bullish | Relevance: 96%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, following a strong third quarter and impressive stock performance. The company's valuation narrative suggests it is 8.1% undervalued with a fair value of $84.70, despite market ratios flashing a caution sign with a higher price-to-sales ratio compared to peers. Ventas' strategy involves active portfolio management and strategic acquisitions to drive revenue and FFO per share growth.

**4. Has Alexandria Real Estate Equities Fallen Too Far After Its 52% Slide in 2025?**
- Source: Simply Wall Street | 20251214T192803 | Neutral | Relevance: 64%
- Alexandria Real Estate Equities has experienced a significant 52% slide year-to-date in 2025, but recent analysis suggests it may be undervalued. Discounted Cash Flow and Price to Sales ratios indicate the stock could be trading at a substantial discount compared to its intrinsic value and industry peers, despite concerns about life sciences office demand and interest rates. Investors can use "Narratives" to align their views with financial projections and determine whether to buy, hold, or sell the stock.

**5. MASTERINVEST Kapitalanlage GmbH Purchases Shares of 17,911 Welltower Inc. $WELL**
- Source: MarketBeat | 20251214T140848 | Somewhat-Bullish | Relevance: 61%
- MASTERINVEST Kapitalanlage GmbH acquired 17,911 shares of Welltower Inc. (NYSE:WELL) in the second quarter, valued at approximately $2.75 million, signaling new institutional interest. Welltower reported a slight EPS beat and strong revenue growth, with analysts giving it a "Moderate Buy" rating and an average price target near $195.87. However, the company has a high trailing P/E ratio and a high dividend payout ratio.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 13 ($23.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Heavy insider selling: $23M sold (13 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +16%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.8B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 138.5 |
| Current P/E | 289.8 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -4.6% to -1.5% (+3.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.3%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-0.55), momentum weakening. RSI neutral at 51. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.52% (CS: 29) | Neutral |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | -0.55 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 1.139x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.24
- **Stop Loss:** $75.32 (3.7% risk)
- **Target:** $81.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 410
- **Position Value:** $32,078.40
- **Portfolio %:** 32.08%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*